PMID- 23157793 OWN - NLM STAT- MEDLINE DCOM- 20140121 LR - 20121119 IS - 1440-0960 (Electronic) IS - 0004-8380 (Linking) VI - 53 IP - 4 DP - 2012 Nov TI - Febrile ulceronecrotic Mucha-Habermann disease: a case with systemic symptoms managed with subcutaneous methotrexate. PG - e83-6 LID - 10.1111/j.1440-0960.2011.00812.x [doi] AB - Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) is a rare, idiopathic, acquired dermatosis that can affect all ages and ethnic groups. We present a 10-year-old patient with FUMHD associated with arthritis and chronic fatigue, managed with methotrexate. Through our literature review, we also explore treatment protocols for a disease for which internationally standardized management is yet to be formulated. CI - (c) 2011 The Authors. Australasian Journal of Dermatology (c) 2011 The Australasian College of Dermatologists. FAU - Lin, Chin-Yun AU - Lin CY AD - Department of Dermatology, Auckland City Hospital, Auckland, New Zealand. cyf.trust@gmail.com FAU - Cook, Jason AU - Cook J FAU - Purvis, Diana AU - Purvis D LA - eng PT - Case Reports PT - Journal Article DEP - 20110920 PL - Australia TA - Australas J Dermatol JT - The Australasian journal of dermatology JID - 0135232 RN - 0 (Dermatologic Agents) RN - YL5FZ2Y5U1 (Methotrexate) RN - Febrile Ulceronecrotic Mucha-Habermann disease SB - IM MH - Arthritis/*complications MH - Child MH - Dermatologic Agents/administration & dosage/*therapeutic use MH - Fatigue/*complications MH - Herpes Simplex/*complications/*drug therapy MH - Humans MH - Male MH - Methotrexate/administration & dosage/*therapeutic use MH - Pityriasis Lichenoides/*complications/*drug therapy EDAT- 2012/11/20 06:00 MHDA- 2014/01/22 06:00 CRDT- 2012/11/20 06:00 PHST- 2012/11/20 06:00 [entrez] PHST- 2012/11/20 06:00 [pubmed] PHST- 2014/01/22 06:00 [medline] AID - 10.1111/j.1440-0960.2011.00812.x [doi] PST - ppublish SO - Australas J Dermatol. 2012 Nov;53(4):e83-6. doi: 10.1111/j.1440-0960.2011.00812.x. Epub 2011 Sep 20.